New Stock News | Zh hu kung y tnggu gng jio su lngtng gngs dxi kung chng de zng kungsh chling d 1062.3 wn tng
According to the disclosure by the Hong Kong Stock Exchange on December 5th, Tibet Zhuhui Mining Co., Ltd. (referred to as Zhuhui Mining) conducted a listing hearing on the main board of the Hong Kong Stock Exchange, with Guojin Securities (Hong Kong) and Maisi Capital acting as its joint sponsors.
According to the disclosure of the Hong Kong Stock Exchange on December 5th, Tibet Zhixing Mining Co., Ltd. (referred to as Zhixing Mining) conducted a listing hearing on the Main Board of Hong Kong Stock Exchange, with Sinolink (Hong Kong) and Maison Capital as its joint sponsors. According to an independent technical report, the total ore reserves of Zhixing Mining's underground mine are 10.623 million tons, with average grades of 4.14% zinc, 2.99% lead, 0.21% copper, and 35.00 grams/ton silver. The ore reserves are divided into primary ore and oxide ore.
The prospectus shows that Zhixing Mining was established in 2013 and is a mining company specializing in exploration, mining, concentrate production, and sales of zinc, lead, and copper in Tibet, China.
According to data from the Shanghai Nonferrous Metals Network, based on the average annual production of zinc concentrate, lead concentrate, and copper concentrate in Tibet in 2024, the company ranked fifth, fourth, and fifth respectively. In 2024, the company accounted for 11.1% of the total zinc concentrate production, 4.2% of the total lead concentrate production, and 0.1% of the total copper concentrate production in Tibet. Lead and copper concentrate production in Tibet is dominated by leading companies. In 2024, the two largest companies in Tibet accounted for 36.1% and 31.6% of the total lead concentrate production market share, while the two largest companies in Tibet accounted for 44.2% and 42.3% of the total copper concentrate production market share.
The company's mining operations are located in Rongduo Township, Jiali County, Nagqu City, Tibet. The company's Moya'a Mine includes an open-pit mine that has been in commercial operation since 2007 and an underground mine that began commercial operation in the second quarter of 2025. The company's mining operations are located in the national designated Jingda Integrated Exploration Area, at elevations between 5,000.0 meters and 5,300.0 meters, containing abundant mineral resources. The company holds exploration rights of approximately 58.5 square kilometers and mining rights of approximately 4.5 square kilometers.
Zhixing Mining has a business operation chain covering exploration, mining, concentrate production, and sales. The company's main products include zinc concentrate, lead concentrate, and copper concentrate. The company's revenue comes from selling these concentrates to customers in China, including non-ferrous metal traders and refining plants. Traders generally resell the concentrates to end-users, while refineries further refine the concentrates based on customer demand. Non-ferrous metal traders purchase the concentrates from the company, then resell them to refineries for profit. Refinery customers are located throughout China, many of which are listed companies or state-owned enterprises. Refineries refine zinc, lead, and copper concentrates into metal ingots.
In terms of financials, the company recorded revenues of 482 million yuan, 546 million yuan, 301 million yuan, and 257 million yuan in the years 2022, 2023, 2024, and January to July 2025, respectively. During the same periods, the company's owners' share of annual profits and comprehensive income amounted to 118 million yuan, 155 million yuan, 55.854 million yuan, and 51.737 million yuan.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






